Literature DB >> 8004313

Extracorporeal carbon dioxide removal technique improves oxygenation without causing overinflation.

F Brunet1, J P Mira, M Belghith, M Monchi, B Renaud, L Fierobe, I Hamy, J F Dhainaut, J Dall'ava-Santucci.   

Abstract

Extracorporeal CO2 removal combined with low frequency positive pressure ventilation (ECCO2R-LFPPV) improves gas exchange and decreases peak pressures, respiratory rates, and tidal volumes in animals and in humans. Recent evidence suggests that pulmonary barotrauma results from lung overinflation rather than from high pressures. This study was to test the hypothesis whether ECCO2R-LFPPV could improve gas exchange without causing lung overinflation, despite the use of higher levels of PEEP, when compared with conventional mechanical ventilation. Eleven patients with severe adult respiratory distress syndrome (ARDS) who failed to respond to different modes of mechanical ventilation were treated with ECCO2R-LFPPV. Risk of pulmonary barotrauma was evaluated by static pressure-volume (P-V) curves and dynamic changes in volumes monitored by respiratory inductive plethysmography (Respitrace). ECCO2R-LFPPV PaO2/FIO2 increased from 79 +/- 21 to 207 +/- 108 (p = 0.003). Risk of barotrauma, as shown by the shape of the P-V curve, was present in all patients receiving mechanical ventilation even though most of them were treated with permissive hypoventilation. By contrast, no evidence of persistent lung overinflation could be detected by either static P-V curves or dynamic measurements in nine of 11 patients who were treated by ECCO2R-LFPPV. The two remaining patients had severe airway obstruction because of bleeding, and they remained ventilated with persistent risk of barotrauma. We conclude that ECCO2R-LFPPV improves gas exchange without causing lung overinflation in a majority of patients with ARDS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8004313     DOI: 10.1164/ajrccm.149.6.8004313

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  6 in total

1.  Extracorporeal life support for 100 adult patients with severe respiratory failure.

Authors:  S Kolla; S S Awad; P B Rich; R J Schreiner; R B Hirschl; R H Bartlett
Journal:  Ann Surg       Date:  1997-10       Impact factor: 12.969

2.  The acute respiratory distress syndrome: definitions, severity and clinical outcome. An analysis of 101 clinical investigations.

Authors:  P Krafft; P Fridrich; T Pernerstorfer; R D Fitzgerald; D Koc; B Schneider; A F Hammerle; H Steltzer
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

Review 3.  Mechanical ventilation during extracorporeal life support (ECLS): a systematic review.

Authors:  Jonathan D Marhong; Laveena Munshi; Michael Detsky; Teagan Telesnicki; Eddy Fan
Journal:  Intensive Care Med       Date:  2015-03-10       Impact factor: 17.440

Review 4.  Bench to bedside review: Extracorporeal carbon dioxide removal, past present and future.

Authors:  Matthew E Cove; Graeme MacLaren; William J Federspiel; John A Kellum
Journal:  Crit Care       Date:  2012-09-21       Impact factor: 9.097

Review 5.  Current Applications for the Use of Extracorporeal Carbon Dioxide Removal in Critically Ill Patients.

Authors:  Luigi Camporota; Nicholas Barrett
Journal:  Biomed Res Int       Date:  2016-02-04       Impact factor: 3.411

Review 6.  Extracorporeal carbon dioxide removal for patients with acute respiratory failure secondary to the acute respiratory distress syndrome: a systematic review.

Authors:  Marianne Fitzgerald; Jonathan Millar; Bronagh Blackwood; Andrew Davies; Stephen J Brett; Daniel F McAuley; James J McNamee
Journal:  Crit Care       Date:  2014-05-15       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.